Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2011 | 03-2011 | 12-2010 | 09-2010 | 06-2010 | |
| Sales | 74,407 | 2,388 | 2,157 | 1,967 | 2,305 |
| Gross Profit | 74,407 | 2,388 | 2,157 | 1,967 | 2,305 |
| Operating Expenses | 18,937 | 25,333 | 21,068 | 19,085 | 17,562 |
| Operating Income | 55,470 | -22,945 | -18,911 | -17,118 | -15,257 |
| Other Income | 16 | 18 | 16 | 17 | 16 |
| Pre-tax Income | 55,486 | -22,927 | -18,895 | -17,101 | -15,241 |
| Net Income Continuous | 55,486 | -22,927 | -18,800 | -17,101 | -15,241 |
| Net Income | $55,486 | $-22,927 | $-18,800 | $-17,101 | $-15,241 |
| EPS Basic Total Ops | 1.66 | -0.69 | -0.57 | -0.52 | -0.47 |
| EPS Basic Continuous Ops | 1.66 | -0.69 | -0.57 | -0.52 | -0.47 |
| EPS Diluted Total Ops | 1.64 | -0.69 | -0.57 | -0.52 | -0.47 |
| EPS Diluted Continuous Ops | 1.64 | -0.69 | -0.57 | -0.52 | -0.47 |
| EBITDA(a) | $55,995 | $-22,409 | $-18,341 | $-16,586 | $-14,383 |